Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study examines the effect of telbivudine compared to lamivudine on the early viral
kinetics in patients with chronic hepatitis B. The virus Kinetics is measured by the viral
load (HBV-DNA) reduction in the serum during the first 12 weeks of therapy.